The E5 protein of the human papillomavirus type 16 down-regulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cells
2007

HPV16 E5 Protein and HLA-I Surface Expression

Sample size: 5 publication 10 minutes Evidence: high

Author Information

Author(s): Myriam Gruener, Ignacio G Bravo, Frank Momburg, Angel Alonso, Pascal Tomakidi

Primary Institution: German Cancer Research Center, Heidelberg, Germany

Hypothesis

The chaperone calnexin is involved in the E5-mediated down-regulation of HLA-I surface expression.

Conclusion

HPV16 E5 down-regulates HLA-I surface expression through a mechanism involving calnexin.

Supporting Evidence

  • HPV16 E5 expression leads to a significant down-regulation of HLA-I surface expression.
  • Calnexin is necessary for the E5-mediated down-regulation of HLA-I.
  • Mutant E5 proteins that do not bind calnexin fail to down-regulate HLA-I.
  • Co-immunoprecipitation experiments show that E5 and calnexin interact.
  • Down-regulation of HLA-I was not observed in calnexin-deficient cells.

Takeaway

The HPV16 E5 protein can make it harder for the body to recognize infected cells by lowering the amount of a protein called HLA-I on their surface, but it only works when another protein, calnexin, is present.

Methodology

Cells were transfected with HPV16 E5 and analyzed for HLA-I surface expression using flow cytometry and immunoprecipitation.

Potential Biases

Potential bias in the interpretation of results due to reliance on specific experimental conditions.

Limitations

The study primarily focuses on specific cell lines and may not fully represent all cellular contexts.

Participant Demographics

Human cell lines were used, including calnexin-expressing and calnexin-deficient variants.

Statistical Information

P-Value

p ≤ 0.001

Statistical Significance

p ≤ 0.001

Digital Object Identifier (DOI)

10.1186/1743-422X-4-116

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication